Jane Kasten-Jolly*, Nataliya Yuklyaeva, Jennifer Victory, Melissa Scribani, Erica Lasek-Nesselquist, Afeefa Shahnawaz, Donald Raddatz and David A. Lawrence
The objective of the study was to compare and characterize the response to the 2014/2015 season influenza vaccine in patients with Rheumatoid Arthritis (RA) receiving biological agents, either TNF α blockers or a T-cell activation blocker, abatacept...